Issue 4/2012

Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology (355 — 360)

W. T. HUANG, L. Y. LI, J. PANG, X. X. RUAN, Q. P. SUN, W. J. YANG, X. GAO

DOI: 10.4149/neo_2012_046

Cellular stress response in Eca-109 cells inhibits apoptosis during early exposure to isorhamnetin (361 — 369)

C. SHI, L. Y. FAN, Z. CAI, Y. Y. LIU, C. L. YANG

DOI: 10.4149/neo_2012_047

Phase I study of docetaxel, cisplatin and concurrent radiotherapy for locally advanced gastric adenocarcinoma (370 — 375)

L. XING, H. LU, J. ZHANG, J. YU, F. WANG, X. YU, H. YU, L. XIA

DOI: 10.4149/neo_2012_048

Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients (376 — 383)

I. RAKO, J. JAKIC-RAZUMOVIC, D. KATALINIC, J. SERTIC, S. PLESTINA

DOI: 10.4149/neo_2012_049

Altered angiogenesis gene expression in gastrointestinal stromal tumors: potential use in diagnosis, outcome prediction, and treatment (384 — 392)

YI ZHAO, Q. WANG, X. DENG, Y. ZHAO

DOI: 10.4149/neo_2012_050

Increased ischemia-modified albumin levels in patients with gastric cancer (393 — 397)

E. FIDAN, A. MENTESE, H. KAVGACI, A. OREM, S. FIDAN, A. UZUN, F. OZDEMIR, F. AYDIN

DOI: 10.4149/neo_2012_051

Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16INK4a expression, and HPV status (398 — 408)

J. LACO, J. NEKVINDOVA, V. NOVAKOVA, P.  CELAKOVSKY, H. DOLEZALOVA, L. TUCEK, H. VOSMIKOVA, M. VOSMIK, T. NESKUDLOVA, E. CERMAKOVA, M. HACOVA, F. A. SOBANDE, A. RYSKA

DOI: 10.4149/neo_2012_052

Overexpression of ECM1 Contributes to Migration and Invasion in Cholangiocarcinoma Cell (409 — 415)

G. P. XIONG, J. X. ZHANG, S. P. GU, Y. B. WU, J. F. LIU

DOI: 10.4149/neo_2012_053

ΔNp63α mediates proliferation and apoptosis in human gastric cancer cells by the regulation of GATA-6 (416 — 423)

H. WANG, Z. LIU, J. LI, X. ZHAO, Z. WANG, H. XU

DOI: 10.4149/neo_2012_054

Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer (424 — 432)

A. KOLACINSKA, J. CHALUBINSKA, I. ZAWLIK, B. SZYMANSKA, E. BOROWSKA-GARGANISZ, M. NOWIK, W. FENDLER, R. KUBIAK, Z. PAWLOWSKA, Z. MORAWIEC, J. SZEMRAJ

DOI: 10.4149/neo_2012_055

Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: Correlations with patient survival and pleural effusion control (433 — 439)

Q. QIAN, P. ZHAN, W. K. SUN, Y. ZHANG, Y. SONG, L. K. YU

DOI: 10.4149/neo_2012_056

Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma – Phase II study results (440 — 449)

L. ZAHRADOVA, K. MOLLOVA, D. OCADLIKOVA, L. KOVAROVA, Z. ADAM, M. KREJCI, L. POUR, A. KRIVANOVA, V. SANDECKA, R. HAJEK

DOI: 10.4149/neo_2012_057

Tumor-specific histone signature and DNA methylation in multiple myeloma and leukemia cells (450 — 462)

V. FOLTANKOVA, S. LEGARTOVA, S. KOZUBEK, E. BARTOVA

DOI: 10.4149/neo_2012_058

Chromosomal Rearrangements In Lymphocytes Of Head and Neck Squamous Cell Carcinoma Treated With Chemotherapeutic Agents (463 — 468)

B. DESAI, P. GADHIA

DOI: 10.4149/neo_2012_059

Melatonin enhanced bexarotene efficacy in experimental mammary carcinogenesis (469 — 474)

P. ORENDAS, P. KUBATKA, K. KAJO, N. STOLLAROVA, M. KASSAYOVA, B. BOJKOVA, M. PEC, V. NOSAL, T. KISKOVA, K. ZIHLAVNIKOVA, R. KARSNAKOVA

DOI: 10.4149/neo_2012_060